Drug intelligence / Profile preview

tranexamic acid + lidocaine + epinephrine

Development stage
Unknown
Lead developer
Avenacy
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Subcutaneous, Topical
01

Overview

The combination of tranexamic acid (TXA), lidocaine, and epinephrine is used in various surgical procedures to manage bleeding and provide local anesthesia. ## Efficacy and Usage This drug combination has been studied in several surgical contexts, particularly in plastic surgery procedures like blepharoplasty (eyelid surgery) and facelifts. The components serve different purposes: - **Tranexamic acid (TXA)**: An anti-fibrinolytic agent that helps reduce bleeding - **Lidocaine**: A local anesthetic that provides pain relief - **Epinephrine**: A vasoconstrictor that reduces bleeding by constricting blood vessels Interestingly, a prospective randomized control trial found that TXA combined with lidocaine and epinephrine actually **increased** intraoperative bleeding compared to lidocaine with epinephrine alone during upper blepharoplasty. This contradicts the expected outcome, as TXA is typically used to reduce bleeding. In contrast, for facelift surgery, local infiltration of TXA combined with lidocaine and epinephrine solution was found to decrease rebound bleeding and reduce the time required to gain hemostasis. The total surgical time saving was approximately 25 to 60 minutes. ## Administration Methods The combination is typically administered through: 1. Subcutaneous injection around the surgical site 2. Local infiltration before surgical procedures 3. Application of gauze impregnated with the solution on surgical wounds ## Safety Considerations The researchers who found increased bleeding with this combination in blepharoplasty concluded that "TXA combined with lidocaine and epinephrine injected subcutaneously should be avoided until additional relevant data are obtained". They recommended further drug interaction studies between TXA and epinephrine. For patients considering this combination, it's important to note that the efficacy may vary depending on the specific surgical procedure and individual factors.

Other names
combination of tranexamic acid (TXA), lidocaine, and epinephrine
02

Targets

PLG (Plasminogen)AR (Adrenergic receptors)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on tranexamic acid + lidocaine + epinephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tranexamic acid + lidocaine + epinephrine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call